Related Experiment Video

Updated: Jun 24, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Immediate postoperative death due to hypothalamic injury following surgery for craniopharyngioma

Biji Bahuleyan1, Girish Menon, Suresh Nair

  • 1Department of Neurosurgery, Sri Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 695 011, India.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|March 20, 2009
PubMed

Insights

Rare deaths after craniopharyngioma surgery can occur from hypothalamic injury. This case highlights the mechanisms, manifestations, and prevention strategies for this severe complication.

Area of Science:

  • Neurosurgery
  • Pediatric Oncology
  • Endocrinology

Background:

  • Craniopharyngioma surgery, particularly radical excision, carries risks.
  • Hypothalamic injury is a known but infrequent complication.
  • Postoperative autonomic dysfunction can be fatal.

Observation:

  • A child underwent radical excision for a multi-compartmental craniopharyngioma.
  • The patient experienced fatal autonomic disturbances secondary to hypothalamic injury.
  • This outcome underscores the critical role of the hypothalamus in postoperative recovery.

Findings:

  • Hypothalamic injury can lead to severe autonomic dysregulation.
  • Mechanisms include direct surgical trauma and secondary effects.
  • Clinical manifestations range from hormonal imbalances to cardiovascular instability.

Implications:

  • Careful surgical technique is paramount to minimize hypothalamic damage.
  • Intraoperative monitoring and postoperative management are crucial.
  • Understanding these risks can improve patient outcomes and survival rates in craniopharyngioma surgery.

More Related Videos

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Related Concept Videos

Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...